#60 – Going MAD for Non-COVID ID Literature: A Year in Review LIVE from MAD-ID
Breakpoints22 Heinä 2022

#60 – Going MAD for Non-COVID ID Literature: A Year in Review LIVE from MAD-ID

In this special LIVE podcast episode, Drs. Emily Heil (@emilylheil) and Erin McCreary (@Erin McCreary) sit down at MAD-ID 2022 (@MAD_ID_ASP) and give a rundown of 36 of some of the best ID papers, abstracts, studies, and other cool stuff from 2021 and early 2022! They cover everything from ECCMID late breakers to gram-negative RCTs to stewardship to fungi (but NOT COVID-19). Listen now!

Handout: https://drive.google.com/file/d/1OdYP9WpNGFmslw_G_vTPYF0cJZoxN8jo/view

LinkedIn: https://www.linkedin.com/company/sidp/ Learn more about the Society of Infectious Diseases Pharmacists: https://sidp.org/About Twitter: @SIDPharm (https://twitter.com/SIDPharm) Instagram: @SIDPharm (https://www.instagram.com/sidpharm/) Facebook: https://www.facebook.com/sidprx

References PMIDs

  1. IMPRESU: 34620666
  2. TARGET: 35106617
  3. MERINO-2: 34395716
  4. Tazobactam SIDP Insight: 34689349
  5. TMP-SMX vs FQ for Steno: 35097154
  6. Elexacaftor-Tezacaftor-Ivacaftor: 35142340
  7. Antibiotic Inertia: 34596206
  8. Antibiotic Overuse at Discharge: 34554249
  9. Pharmacist-Driven TOC: 35536577
  10. Tele-stewardship: 34141816
  11. MRSA Surveillance Culture: 29340593
  12. MRSA Screen Durability: 33788910
  13. Antifungal Pipeline: 34626339
  14. Antifungal Susceptibility Testing: 347784889
  15. Posa vs Vori for Aspergillosis: 33549194
  16. AMBITION: 35320642
  17. FLAGSTONE: 35085510
  18. SOLSTICE: 34864943
  19. Probiotics for Primary Prevention: 33972996
  20. Probiotics and VAP: 34546300
  21. SER-109: 35045228
  22. Bayesian vs First-Order Vanc AUC: 35134264
  23. Beta-lactam Admin Order: 34606585
  24. Candida Endophthalmitis: 34293405
  25. FUO Review: 35108471
  26. 7 vs 14 Days for Male UTI: 34313686

Check out our podcast host, Pinecast. Start your own podcast for free with no credit card required. If you decide to upgrade, use coupon code r-7e7a98 for 40% off for 4 months, and support Breakpoints.

Tämä jakso on lisätty Podme-palveluun avoimen RSS-syötteen kautta eikä se ole Podmen omaa tuotantoa. Siksi jakso saattaa sisältää mainontaa.

Jaksot(135)

#55 – One World: Global Perspectives in Antimicrobial Stewardship

#55 – One World: Global Perspectives in Antimicrobial Stewardship

Drs. Debbie Goff (@idpharmd), Khalid Eljaaly (@khalideljaaly), and Angeliki Messina (@AngPharmID) join Dr. David Ha (@DHpharmd) as part of a global panel discussion on international antimicrobial stew...

25 Maalis 20221h 27min

#54 – Connecting with our Colleagues: COVID-19 Treatments in Community Pharmacies

#54 – Connecting with our Colleagues: COVID-19 Treatments in Community Pharmacies

Dr. Jennifer Morrow joins Dr. Rachel Britt (@RachelBPharmD) on this bonus episode of the Breakpoints podcast to discuss how the introduction of COVID-19 therapeutics and vaccines has affected communit...

18 Maalis 202234min

#53 – Abscessus and fortuitum and avium, Oh My!: Updates and Controversies in NTM Management

#53 – Abscessus and fortuitum and avium, Oh My!: Updates and Controversies in NTM Management

Drs. Wendi Drummond and Jeff Pearson (@jeffpears0n) join Dr. Rachel Britt (@RachelBPharmD) on the Breakpoints podcast this week to discuss all things on non-tuberculosis mycobacteria pulmonary infecti...

18 Helmi 20221h 11min

#52 – A Conversation with the Authors of IDSA Guidance on Treatment of AmpC, CRAB, and Stenotrophomonas

#52 – A Conversation with the Authors of IDSA Guidance on Treatment of AmpC, CRAB, and Stenotrophomonas

Drs. Pranita Tamma (@pranita_tamma) and Sam Aitken (@OncIDPharmd) are BACK on the podcast this week with Dr. Erin McCreary (@ErinMcCreary) to discuss IDSA guidance on AmpC producers, carbapenem-resist...

28 Tammi 20221h 13min

#51 – A Conversation with the Authors of IDSA Guidance on Treatment of ESBL, CRE, and DTR Pseudomonas

#51 – A Conversation with the Authors of IDSA Guidance on Treatment of ESBL, CRE, and DTR Pseudomonas

Drs. Pranita Tamma (@pranita_tamma) and Sam Aitken (@OncIDPharmd), authors of the IDSA Guidance on gram-negative resistance, join Dr. Erin McCreary (@ErinMcCreary) for this exquisitely good episode to...

21 Tammi 20221h 15min

#50 – Moving to the Algo-rhythm of IDWeek 2021: Highlights in SoMe and ASP

#50 – Moving to the Algo-rhythm of IDWeek 2021: Highlights in SoMe and ASP

Episode Notes Drs. Timothy Gauthier (@IDstewardship) and Jillian Hayes (@thejillianhayes) join Dr. Zahra Kassamali Escobar (@zkePharmD) to recap some IDWeek 2021 highlights on social media and antimic...

17 Joulu 20211h 1min

#49 – A PGY-What Now? A Primer on ID Pharmacy Fellowships

#49 – A PGY-What Now? A Primer on ID Pharmacy Fellowships

Episode Notes Drs. Keith Rodvold and Taylor Morrisette (@TayMorrisette) join Dr. Julie Ann Justo (@julie_justo) to discuss ID pharmacy fellowships, their pros and cons compared to other post-graduate ...

3 Joulu 202151min

#48 – Aligning Goals: Antibiotics in End of Life Care

#48 – Aligning Goals: Antibiotics in End of Life Care

Drs. Molly Sinert and Jon Furuno join Dr. David Ha (@DHpharmd) to discuss the prevalence of antibiotic use and its harms and benefits in reducing suffering and providing comfort during end-of-life car...

19 Marras 20211h

Suosittua kategoriassa Koulutus

rss-murhan-anatomia
psykopodiaa-podcast
voi-hyvin-meditaatiot-2
adhd-podi
rss-rahamania
rss-liian-kuuma-peruna
psykologia
rss-laadukasta-ensihoitoa
rss-narsisti
rss-vapaudu-voimaasi
kesken
rss-niinku-asia-on
rss-arkea-ja-aurinkoa-podcast-espanjasta
rss-hereilla
rahapuhetta
rss-keskeneraiset-aidit
ihminen-tavattavissa-tommy-hellsten-instituutti
rss-duodecim-lehti
rss-valo-minussa-2
rss-tfa-8020-podcast